Moberg Pharma AB (publ) (MOB) — Cash Flow Quality Index
Moberg Pharma AB (publ) (MOB) has a Cash Flow Quality Index of -0.70x as of September 2019. Operating cash flow of Skr-29.30 Million is below net income of Skr41.76 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Moberg Pharma AB (publ) cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Moberg Pharma AB (publ) Cash Flow Quality Index (2012–2021)
Historical Cash Flow Quality Index for Moberg Pharma AB (publ) across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check MOB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Moberg Pharma AB (publ) (2012–2021)
Year-by-year earnings quality comparison for Moberg Pharma AB (publ). For live market cap and the full company financial profile, see MOB company net worth.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.04x | Skr-15.30 Million | Skr7.49 Million | ▼ -1134.5% |
| 2019 | 0.20x | Skr3.95 Million | Skr20.02 Million | ▼ -82.7% |
| 2018 | 1.14x | Skr73.89 Million | Skr64.82 Million | ▲ +8.2% |
| 2017 | 1.05x | Skr53.82 Million | Skr51.07 Million | ▲ +465.2% |
| 2016 | -0.29x | Skr-17.94 Million | Skr62.17 Million | ▼ -133.1% |
| 2015 | 0.87x | Skr30.72 Million | Skr35.18 Million | ▼ -6.9% |
| 2014 | 0.94x | Skr16.16 Million | Skr17.23 Million | ▲ +24.7% |
| 2012 | 0.75x | Skr9.48 Million | Skr12.59 Million | — |